Form 8-K MAIA Biotechnology, Inc. For: Nov 10
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
MAIA Biotechnology (MAIA) Suspends Common Stosk Sales
November 15, 2023 8:49 AM ESTOn November 15, 2023, MAIA Biotechnology (NYSE: MAIA) suspended sales of its common stock, par value $0.0001 per share (Common Stock), pursuant to that certain Sales Agreement, dated as of September 1, 2023 (the Sales Agreement), between the Company and ThinkEquity LLC (the Agent), the Companys sales agent thereunder, and... More



